Remote Temperature Monitoring Using a Wearable Thermometer for Cancer Patients at Risk of Fever

What this Trial Is About

This research aims to evaluate continuous remote temperature monitoring in cancer patients who are at risk of developing fever and infection due to chemotherapy treatment. The study focuses on whether this monitoring can reduce the number of days patients spend hospitalized, the out-of-pocket costs they might face, and the number of billable medical codes generated. The program compares patients who comply with the remote temperature monitoring to those who do not, to see if compliance is linked to fewer inpatient days. Participants will wear a wearable thermometer device throughout their study participation, allowing 247 remote temperature monitoring. Physicians can configure alert thresholds for sustained high temperatures, triggering notifications sent to patients phones. Participants will receive alerts when their temperature exceeds these limits and will be contacted by remote monitors via text or phone calls when an alert occurs. During the study, patients will be monitored continuously and their temperature data collected. Researchers will measure the average number of inpatient days from enrollment up to 180 days, along with participants out-of-pocket costs and the number of billing codes generated. The study involves completing surveys, responding to alerts, and using the TempShield app. Safety and compliance will be tracked over a maximum participation period of 180 days after enrollment.

Remote Temperature Monitoring of Patients At Risk for Developing Fever